Peterson Eric D, Spertus John A, Cohen David J, Hlatky Mark A, Go Alan S, Vickrey Barbara G, Saver Jeffrey L, Hinton Patricia C
Duke Outcomes Research Center, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27705, USA.
Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):663-70. doi: 10.1161/CIRCOUTCOMES.109.868612.
The field of outcomes research seeks to define optimal treatment in practice and to promote the rapid full adoption of efficacious therapies into routine clinical care. The American Heart Association (AHA) formed the AHA Pharmaceutical Roundtable (PRT) Outcomes Research Centers Network to accelerate attainment of these goals. Participating centers were intended to carry out state-of-the-art outcomes research in cardiovascular disease and stroke, to train the next generation of investigators, and to support the formation of a collaborative research network.
After a competitive application process, 4 AHA PRT Outcomes Research Centers were selected: Duke Clinical Research Institute; Saint Luke's Mid America Heart Institute; Stanford University-Kaiser Permanente of Northern California; and University of California, Los Angeles. Each center proposed between 1 and 3 projects organized around a single theme in cardiovascular disease or stroke. Additionally, each center will select and train up to 6 postdoctoral fellows over the next 4 years, and will participate in cross-collaborative activities among the centers.
The AHA PRT Outcomes Research Centers Network is designed to further strengthen the field of cardiovascular disease and stroke outcomes research by fostering innovative research, supporting high quality training, and encouraging center-to-center collaborations.
结果研究领域旨在确定实际中的最佳治疗方法，并促进将有效疗法迅速全面应用于常规临床护理。美国心脏协会（AHA）成立了AHA药物圆桌会议（PRT）结果研究中心网络，以加速实现这些目标。参与中心旨在开展心血管疾病和中风领域的前沿结果研究，培养下一代研究人员，并支持建立合作研究网络。
经过竞争性申请程序，4个AHA PRT结果研究中心被选中：杜克临床研究所；圣卢克中美心脏研究所；斯坦福大学 - 北加利福尼亚凯撒医疗机构；以及加利福尼亚大学洛杉矶分校。每个中心围绕心血管疾病或中风的单一主题提出了1至3个项目。此外，每个中心将在未来4年内选拔并培训多达6名博士后研究员，并将参与各中心之间的交叉合作活动。
AHA PRT结果研究中心网络旨在通过促进创新研究、支持高质量培训以及鼓励中心间合作，进一步加强心血管疾病和中风结果研究领域。
